Neutropenia is an uncommon feature of rheumatoid arthritis. Although it may be seen as an isolated extra-articular manifestation of the disease it is commonly associated with splenomegaly and referred to as Felty's syndrome. The mechanism of neutropenia in RA is unclear but probably multifactorial, reflecting the balance between marrow neutrophil reserves and release, and peripheral neutrophil consumption, destruction, and sequestration. This study was undertaken to assess some of the factors which may influence this balance.
Marrow neutrophil reserves have been tested by a hydrocortisone stimulation test to determine whether reduced reserves may contribute to the leucopenia. The (ARA criteria5 ) and 15 normal controls were studied. All individuals gave their informed consent for investigation.
Twenty-five patients with RA and associated neutropenia were studied and compared with 24 patients with uncomplicated RA. Neutropenia was defined as a neutrophil count of less than 2-0 x 103/mm3 As 19 of our 25 neutropenic patients also had splenomegaly (Felty's syndrome), they were also compared with a second control group consisting of 16 patients with RA and splenomegaly but with persistently normal white counts. Assessment of spleen size was limited to palpation. All patients had long-242 (Table 3) C3 levels were normal or elevated in the majority of patients in all 3 rheumatoid groups. However, depressed C3 levels occurred in 6 of the RA-neutropenia groups but in none of the control groups. Depressed levels of C4 were seen in both the RA splenomegaly and RA-neutropenia groups but not in those patients with uncomplicated RA. Evidence of complement activation was detected in 3 of 6 RA-neutropenia patients tested, there being 50 % activation in 2 patients and 100% in one patient. Complement activation was not detected in any patients in the 2 control groups.
Anticomplementary activity was detected in the sera of 13 of 25 RA-neutropenia patients and in 2 of these in very high titre (>4096). It was present in only 2 of the 16 RA-splenomegaly group but again in very high titre (4096) and in only 1 of the 12 uncomplicated RA group. The platelet aggregation test was positive in 10 of 18 RA-neutropenia patients studied but also in 4 of the 11 RA-splenomegaly group and 1 of the uncomplicated RA group. Circulating immune complexes were detected by one or more of the 3 methods in a total of 17 of 25 RA-neutropenia sera compared with 1 of 12 uncomplicated RA sera (X2 = 9-29; p<001), and 5 of the 16 RA-splenomegaly sera (X2 = 3-92; 001<p<0*05).
There was no correlation between the degree of neutropenia, or the degree of impairment of marrow neutrophil reserve, and the tires of circulating immune complexes.
Discussion
This study was undertaken to assess factors which may influence the development of neutropenia in patients with rheumatoid arthritis. Studies on marrow neutrophil reserve and circulating immune complexes have been performed on 25 patients with rheumatoid arthritis and neutropenia and compared with those on 24 patients with uncomplicated RA. Nineteen of our 25 patients with neutropenia also had splenomegaly and would fulfil accepted clinical criteria for the diagnosis of Felty's syndrome. An additional control group of individuals with rheumatoid arthritis and splenomegaly but without neutropenia have therefore also been studied. Clinically major differences were seen in the groups. As expected, patients with RA and neutropenia had clinical evidence of more severe disease as shown by the presence of rheumatoid nodules, antinuclear antibodies, weight loss, and recurrent infections. Although the mean duration of disease was similar in the groups, an interesting observation was the relative lack of synovitis in the patients with RA and neutropenia when compared with the uncomplicated rheumatoid patients. Perhaps more surprising were the findings in patients with RA and splenomegaly alone. These patients were clinically more similar to the uncomplicated RA patients than the patients with RA and neutropenia. In particular, although they had a slightly shorter duration of disease, a similar prevalence of active synovitis, rheumatoid nodules, and weight loss were noted when compared to the uncomplicated group. Recurrent infections, which were so prevalent in the patients with RA and neutropenia, were not a feature of their disease. Since the clinical association between neutropenia, polyarthritis, and splenomegaly as described by Felty"3 was not a feature of all our patients with neutropenia, it would appear that the presence of neutropenia was of more clinical significance than the presence of splenomegaly. This observation supports the findings in cases described by Spivak, "4 
